Cigna’s second quarter results were met with a significant negative market reaction, reflecting investor concerns despite ...

Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.

Eli Lilly has released Mounjaro KwikPen, a prefilled weekly treatment for type 2 diabetes and obesity in India ...

We are paying the highest drug prices in the world. Americans can’t continue to afford it,” CT Sen. Matt Lesser said.

Eli Lilly launches Mounjaro KwikPen in India, offering adults with type 2 diabetes and obesity a once-weekly, ...

Eli Lilly introduces its Mounjaro Kwikpen in India at ₹14,000 for the 2.5 mg starting dose, competing with Novo Nordisk’s Wegovy in the booming GLP-1 drug market for diabetes and weight loss.